Status:
COMPLETED
Bioavailability of Different Formulas Enriched With DHA Using Wet Mixing or Dry Blending Method
Lead Sponsor:
Indonesian Nutrition Association
Conditions:
Healthy Children
Eligibility:
All Genders
2-3 years
Phase:
NA
Brief Summary
Infants and young children have high nutritional demands in order to support adequate growth and development, particularly during the transition from complementary feeding at 12 months of age to a mix...
Detailed Description
This study will use two phase approaches Phase 1, screening habitual n3 intake. Mothers of healthy toddlers, non-fish or non-n3 supplement babies (aged 2-3 years old) would be invited to complete a Fo...
Eligibility Criteria
Inclusion
- Boys and girls aged 2-3 years old, apparently healthy, living in the study area for minimally one month and parents permit them to participate in the study by signing the informed consent.
Exclusion
- Having milk allergy and/or lactose intolerance, high omega-3 intake habit
Key Trial Info
Start Date :
February 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04460287
Start Date
February 17 2023
End Date
May 30 2024
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sekretariat RW 12 Cipinang besar
Jakarta, DKI Jakarta, Indonesia, 13410